Physician profile
Robert H Sherman
NPI 1447210810
$1,357.31
in general payments reported to CMS, 2019-2025
21 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $219 · 2021: $240 · 2022: $124 · 2023: $183 · 2024: $169 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $208.50 | 2021-2024 | Urolift |
| Rochester Medical Corporation | $175.37 | 2020 | |
| Axonics, INC. | $152.29 | 2022-2024 | Axonics |
| Procept Biorobotics Corporation | $151.99 | 2024-2025 | Aquabeam System |
| Aytu Biopharma, INC. | $139.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $93.29 | 2020-2025 | Lynparza |
| Endo Pharmaceuticals INC. | $66.61 | 2021 | |
| Valencia Technologies Corporation | $59.22 | 2025 | Ecoin Device Kit |
| Laborie Medical Technologies Corp. | $55.23 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Halozyme INC | $45.07 | 2023 | |
| Clarus Therapeutics INC. | $42.53 | 2021 | |
| Boston Scientific Corporation | $26.87 | 2020 | |
| Antares Pharma, INC. | $23.68 | 2024 | Xyosted |
| Verity Pharmaceuticals INC. | $21.13 | 2024 | Tlando |
| Coloplast Corp | $20.44 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $19.88 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.00 | 2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $14.67 | 2021 | |
| Allergan, INC. | $14.44 | 2019 | |
| Photocure INC | $12.03 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.